Stephen Davis, CEO: Acadia Pharmaceuticals ACAD Sell · Filed 24/02/27

Trade details

Type: Insider sale
Amount: $137,584.59
Shares · price: 5,577 sh · $24.67 a share
Held after: 101,890 sh
Stock: Acadia Pharmaceuticals ACAD
Person: Stephen DavisCEO
Trade date: 24/02/26
Filed: 24/02/27
Days to filing: 1 days

Sold 5.2% of holdings

Share of holding sold: 5.2%

Acadia Pharmaceuticals trades, last 26 weeks

What else happened in Acadia Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/01/27~24/03/27

Stephen Davis's recent trades

Stephen DavisCEO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$485.1K
31,747 sh
$485.1K
Filed 24/08/20
Traded 24/08/19
Stephen DavisCEO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$193.6K
11,427 sh
$193.6K
Filed 24/05/03
Traded 24/05/02
Stephen DavisCEO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$316.6K
17,716 sh
$316.6K
Filed 24/04/09
Traded 24/04/08
Stephen DavisCEO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$158.3K
8,858 sh
$158.3K
Filed 24/04/09
Traded 24/04/08
Stephen DavisCEO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$317.1K
17,714 sh
$317.1K
Filed 24/03/27
Traded 24/03/27